A novel KMT2A‐ACTN2 fusion in infant B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

A novel KMT2A‐ACTN2 fusion in infant B‐cell acute lymphoblastic leukemia

Published:2019-05-21 Issue:8 Volume:66 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Yoshida Masanori¹²,Nakabayashi Kazuhiko³,Ogata‐Kawata Hiroko³,Osumi Tomoo¹⁴^ORCID,Tsujimoto Shin‐ichi¹²^ORCID,Shirai Ryota¹²,Yoshida Kaoru¹,Okamura Kohji⁵^ORCID,Matsumoto Kimikazu⁴^ORCID,Kiyokawa Nobutaka¹,Tomizawa Daisuke⁴^ORCID,Hata Kenichiro³,Kato Motohiro¹⁴^ORCID

Affiliation:

1. Department of Pediatric Hematology and Oncology ResearchNational Research Institute for Child Health and Development Tokyo Japan

2. Department of PediatricsYokohama City University Yokohama Japan

3. Department of Maternal‐Fetal BiologyNational Research Institute for Child Health and Development Tokyo Japan

4. Children's Cancer CenterNational Center for Child Health and Development Tokyo Japan

5. Department of Systems BioMedicineNational Research Institute for Child Health and Development Tokyo Japan

Funder

Japan Society for the Promotion of Science

National Center for Child Health and Development

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27821

Reference13 articles.

1. Treatment and biology of pediatric acute lymphoblastic leukemia

2. The MLL recombinome of acute leukemias in 2017

3. Recent progress in the treatment of infant acute lymphoblastic leukemia

4. The actinin family of actin cross-linking proteins – a genetic perspective

5. Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy